Cargando…

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma

Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Menon, Lakshmi P., Rahman, Wedad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261848/ https://www.ncbi.nlm.nih.gov/pubmed/34218714 http://dx.doi.org/10.1177/23247096211029750

Ejemplares similares

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
por: Singh, Pratibha, et al.
Publicado: (2011)

Spontaneous reduction of prolactinoma post cabergoline withdrawal
por: Venkatesh, Sampath Kumar, et al.
Publicado: (2012)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Temporal resolution of idiopathic granulomatous mastitis with resumption of bromocriptine therapy for prolactinoma
por: Bouton, Marcia E., et al.
Publicado: (2015)

Cabergoline-associated valvulopathy of the tricuspid valve in the treatment of prolactinoma
por: Hayes, Annabelle G, et al.
Publicado: (2022)

Cabergoline treatment in prolactinoma: Amelioration in obstructive and central sleep apneas
por: Binar, M, et al.
Publicado: (2019)

Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively
por: Tang, Chao, et al.
Publicado: (2019)

SAT-270 Priapism Secondary to Cabergoline
por: Amir, Maryam, et al.
Publicado: (2020)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report
por: Casulari, Luiz Augusto, et al.
Publicado: (2019)

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
por: Belhadj Slimane, Chayma, et al.
Publicado: (2023)

Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline
por: Astaf’eva, Ludmila, et al.
Publicado: (2020)

Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
por: Oshige, Tamami, et al.
Publicado: (2019)

Management of prolactinoma with cabergoline treatment in a pregnant woman during her entire pregnancy
por: Bajwa, Sukhwinder Kaur, et al.
Publicado: (2011)

Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
por: Singh, Pratibha, et al.
Publicado: (2011)

Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
por: Pala, Nazir A., et al.
Publicado: (2015)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013)

Chronic cluster‐like headache in a patient with a macroprolactinoma presenting with falsely low prolactin levels: bromocriptine versus cabergoline?
por: Pineyro, Maria M., et al.
Publicado: (2017)

Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma
por: Doğan, Berçem Ayçiçek, et al.
Publicado: (2016)

Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022)

Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
por: Almistehi, Wael M, et al.
Publicado: (2018)

Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009)

Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
por: Pirchio, Rosa, et al.
Publicado: (2021)

Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
por: Huang, Jinxiang, et al.
Publicado: (2017)

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats
por: Fouad Shalaby, Mohammed, et al.
Publicado: (2021)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas
por: Xiao, Zhengzheng, et al.
Publicado: (2020)

SAT-246 A Case of Cabergoline Induced Pituitary Apoplexy in a Patient with Prolactinoma
por: Ahuja, Ashim
Publicado: (2020)

Foster Kennedy syndrome secondary to a giant prolactinoma with a remarkable response to cabergoline
por: Kanj, Usama, et al.
Publicado: (2022)

Cabergoline Effectively Induced Remission of Prolactinoma in a 9-year-old Japanese Boy
por: Sano, Hitomi, et al.
Publicado: (2009)

A Novel Case of Spontaneous Coronary Artery Dissection During Cabergoline Therapy for Prolactinoma
por: Ikeda, Shinichiro, et al.
Publicado: (2020)

Binge Eating and Compulsive Buying During Cabergoline Treatment for Prolactinoma: A Case Report
por: Correa e Castro, Ana Carolina, et al.
Publicado: (2022)

Case Report: Persistent erectile dysfunction in a man with prolactinoma
por: Badal, Justin, et al.
Publicado: (2015)

Recurrent priapism in the setting of cannabis use
por: Montgomery, Sebastian, et al.
Publicado: (2020)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tb2ikfabu3ca3tbscr1evis2vp